On the contrary, Leng et al. [20] found that EA can improve obesity and reduce the potential risk of type 2 diabetes via hypothalamic Tsc1 promoter demethylation and by inhibiting the activity of mTORC1 signaling pathway. This evidence concerns the gene TSC1 and type 2 diabetes mellitus.